Development and validation of the self-report symptom inventory of immune-related adverse events in patients with lung cancer
Preliminarily, the SRSI-irAEs-LC is a valid and reliable instrument for assessing symptomatic irAEs in patients with lung cancer treated with PD-1/PD-L1 ICIs. Further research is needed to confirm its generalizability to a broader population as well as its validity and reliability.
Authors
- Graeme D Smith (ORCID: https://orcid.org/0000-0003-2974-3919)
- Siying Zhu (ORCID: https://orcid.org/0009-0006-6990-1765)
- Ying Zhou
- Tiantian Fan (ORCID: https://orcid.org/0000-0002-7794-5577)
- Hong Wang (ORCID: https://orcid.org/0000-0003-0477-2908)
- Yumei Li (ORCID: https://orcid.org/0000-0002-7910-6515)
- Yalan Song
- Shan Pan
- Qiujuan Wu
- Dong Yan
- Yuan Han (ORCID: https://orcid.org/0000-0001-5178-8430)
Institutions
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Guangzhou Medical University Cancer Hospital (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Asia-Pacific Journal of Oncology Nursing
- Published
- 2024-10-12
- DOI
- https://doi.org/10.1016/j.apjon.2024.100603
- Citations
- 3
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Guangzhou Medical University